Significance of Ischemic Heart Disease in Patients with Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study

Circulation: Heart Failure

Volumn 10, Issue 6, 2017, Pages

  Vedin, Ola ^a   Lam, Carolyn S P ^b,c   Koh, Angela S ^b,c   Benson, Lina ^d   Teng, Tiew Hwa Katherine ^b,e   Tay, Wan Ting ^b   Braun, Oscar O ^f   Savarese, Gianluigi ^g,h   Dahlström, Ulf ⁱ   Lund, Lars H ^g,h  

^a UPPSALA UNIVERSITY   (Sweden)

^b DEPARTMENT OF CARDIOLOGY   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d Stockholm Regional Cancer Centre   (Sweden)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f LUND UNIVERSITY   (Sweden)

^g KAROLINSKA INSTITUTE   (Sweden)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ LINKÖPING UNIVERSITY   (Sweden)

Author keywords

acute coronary syndrome; heart failure; outcomes; prevalence; registry

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL OUTCOME; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HOSPITAL DISCHARGE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; VERY ELDERLY; CAUSE OF DEATH; CLINICAL TRIAL; COMPLICATION; HEART STROKE VOLUME; MORTALITY; MULTICENTER STUDY; MYOCARDIAL ISCHEMIA; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; REGISTER; SURVIVAL RATE; SWEDEN; TRENDS;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; FEMALE; HEART FAILURE; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PREVALENCE; PROGNOSIS; REGISTRIES; STROKE VOLUME; SURVIVAL RATE; SWEDEN;

EID: 85021081036     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.117.003875     Document Type: Article

References (38)

1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/ Task Force Members. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129-2200. doi: 10. 1093/eurheartj/ehw128.
2. Lam CS, Solomon SD. The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%). Eur J Heart Fail. 2014;16:1049-1055. doi: 10. 1002/ejhf. 159.
3. Lam CS, Teng TH. Understanding heart failure with mid-range ejection fraction. JACC Heart Fail. 2016;4:473-476. doi: 10. 1016/j. jchf. 2016. 03. 025.
4. Lund LH. Heart failure with "mid-range" ejection fraction-new opportunities. J Card Fail. 2016;22:769-771. doi: 10. 1016/j. cardfail. 2016. 07. 439.
5. Lund LH, Mancini D. Heart failure in women. Med Clin North Am. 2004;88:1321-1345, xii. doi: 10. 1016/j. mcna. 2004. 03. 003.
6. Gerber Y, Weston SA, Berardi C, McNallan SM, Jiang R, Redfield MM, Roger VL. Contemporary trends in heart failure with reduced and preserved ejection fraction after myocardial infarction: a community study. Am J Epidemiol. 2013;178:1272-1280. doi: 10. 1093/aje/kwt109.
7. Badar AA, Perez-Moreno AC, Hawkins NM, Jhund PS, Brunton AP, Anand IS, McKelvie RS, Komajda M, Zile MR, Carson PE, Gardner RS, Petrie MC, McMurray JJ. Clinical characteristics and outcomes of patients with coronary artery disease and angina: analysis of the irbesartan in patients with heart failure and preserved systolic function trial. Circ Heart Fail. 2015;8:717-724. doi: 10. 1161/ CIRCHEARTFAILURE. 114. 002024.
8. Choudhury L, Gheorghiade M, Bonow RO. Coronary artery disease in patients with heart failure and preserved systolic function. Am J Cardiol. 2002;89:719-722.
9. Hwang SJ, Melenovsky V, Borlaug BA. Implications of coronary artery disease in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2014;63(25 pt A):2817-2827. doi: 10. 1016/j. jacc. 2014. 03. 034.
10. Mentz RJ, Broderick S, Shaw LK, Fiuzat M, O'Connor CM. Heart failure with preserved ejection fraction: comparison of patients with and without angina pectoris (from the Duke Databank for Cardiovascular Disease). J Am Coll Cardiol. 2014;63:251-258. doi: 10. 1016/j. jacc. 2013. 09. 039.
11. Shah SJ. Evolving approaches to the management of heart failure with preserved ejection fraction in patients with coronary artery disease. Curr Treat Options Cardiovasc Med. 2010;12:58-75. doi: 10. 1007/ s11936-009-0060-2.
12. Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, Hernandez AF, Fonarow GC. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: Prevalence, therapies, and outcomes. Circulation. 2012;126:65-75.
13. Lund LH, Benson L, Dahlström U, Edner M, Friberg L. Association between use of ?-blockers and outcomes in patients with heart failure and preserved ejection fraction. JAMA. 2014;312:2008-2018. doi: 10. 1001/ jama. 2014. 15241.
14. Coles AH, Fisher K, Darling C, Yarzebski J, McManus DD, Gore JM, Lessard D, Goldberg RJ. Long-term survival for patients with acute decompensated heart failure according to ejection fraction findings. Am J Cardiol. 2014;114:862-868. doi: 10. 1016/j. amjcard. 2014. 06. 017.
15. Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA; Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005;112:3738-3744. doi: 10. 1161/CIRCULATIONAHA. 105. 561423.
16. Gottdiener JS, McClelland RL, Marshall R, Shemanski L, Furberg CD, Kitzman DW, Cushman M, Polak J, Gardin JM, Gersh BJ, Aurigemma GP, Manolio TA. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med. 2002;137:631-639.
17. Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, Tu JV, Levy D. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation. 2009;119:3070-3077. doi: 10. 1161/CIRCULATIONAHA. 108. 815944.
18. Badar AA, Perez-Moreno AC, Hawkins NM, Brunton AP, Jhund PS, Wong CM, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Gardner RS, Petrie MC, McMurray JJ. Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme. Eur J Heart Fail. 2015;17:196-204. doi: 10. 1002/ejhf. 221.
19. Rusinaru D, Houpe D, Szymanski C, Lévy F, Maréchaux S, Tribouilloy C. Coronary artery disease and 10-year outcome after hospital admission for heart failure with preserved and with reduced ejection fraction. Eur J Heart Fail. 2014;16:967-976. doi: 10. 1002/ejhf. 142.
20. Jonsson A, Edner M, Alehagen U, Dahlström U. Heart failure registry: a valuable tool for improving the management of patients with heart failure. Eur J Heart Fail. 2010;12:25-31. doi: 10. 1093/eurjhf/hfp175.
21. Socialstyrelsen [Internet]. http://www. socialstyrelsen. se/. Accessed March 18, 2017.
22. Statistiska centralbyrån SCB [Internet]. http://www. scb. se/. Accessed March 18, 2017.
23. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450. doi: 10. 1186/1471-2458-11-450.
24. Ingelsson E, Arnlöv J, Sundström J, Lind L. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail. 2005;7:787-791. doi: 10. 1016/j. ejheart. 2004. 12. 007.
25. Eriksson A, Stenlund H, Ahlm K, Boman K, Bygren LO, Johansson LA, Olofsson BO, Wall S, Weinehall L. Accuracy of death certificates of cardiovascular disease in a community intervention in Sweden. Scand J Public Health. 2013;41:883-889. doi: 10. 1177/1403494813499653.
26. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702-706.
27. Kapoor JR, Kapoor R, Ju C, Heidenreich PA, Eapen ZJ, Hernandez AF, Butler J, Yancy CW, Fonarow GC. Precipitating clinical factors, heart failure characterization, and outcomes in patients hospitalized with heart failure with reduced, borderline, and preserved ejection fraction. JACC Heart Fail. 2016;4:464-472. doi: 10. 1016/j. jchf. 2016. 02. 017.
28. Cheng RK, Cox M, Neely ML, Heidenreich PA, Bhatt DL, Eapen ZJ, Hernandez AF, Butler J, Yancy CW, Fonarow GC. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. Am Heart J. 2014;168:721-730. doi: 10. 1016/j. ahj. 2014. 07. 008.
29. He KL, Burkhoff D, Leng WX, Liang ZR, Fan L, Wang J, Maurer MS. Comparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions >55% versus 40% to 55% versus <40%. Am J Cardiol. 2009;103:845-851. doi: 10. 1016/j. amjcard. 2008. 11. 050.
30. Uretsky BF, Thygesen K, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Packer M, Poole-Wilson PA, Ryden L. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation. 2000;102:611-616.
31. Henkel DM, Redfield MM, Weston SA, Gerber Y, Roger VL. Death in heart failure: a community perspective. Circ Heart Fail. 2008;1:91-97. doi: 10. 1161/CIRCHEARTFAILURE. 107. 743146.
32. Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G, Rouleau JL; STICHES Investigators. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374:1511-1520. doi: 10. 1056/ NEJMoa1602001.
33. Alehagen U, Benson L, Edner M, Dahlström U, Lund LH. Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure Registry. Circ Heart Fail. 2015;8:252-260. doi: 10. 1161/CIRCHEARTFAILURE. 114. 001730.
34. Alehagen U, Benson L, Edner M, Dahlström U, Lund LH. Association between use of statins and mortality in patients with heart failure and ejection fraction of 50. Circ Heart Fail. 2015;8:862-870. doi: 10. 1161/ CIRCHEARTFAILURE. 115. 002143.
35. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G; Gissi-HF Investigators. Effect of rosuvastatin in patients with chronic heart failure (the GISSIHF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:1231-1239. doi: 10. 1016/S0140-6736(08)61240-4.
36. Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J; PEP-CHF Investigators. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J. 2006;27:2338-2345. doi: 10. 1093/eurheartj/ehl250.
37. Dunlay SM, Roger VL, Weston SA, Jiang R, Redfield MM. Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction. Circ Heart Fail. 2012;5:720-726. doi: 10. 1161/CIRCHEARTFAILURE. 111. 966366.
38. Kalogeropoulos AP, Fonarow GC, Georgiopoulou V, Burkman G, Siwamogsatham S, Patel A, Li S, Papadimitriou L, Butler J. Characteristics and outcomes of adult outpatients with heart failure and improved or recovered ejection fraction. JAMA Cardiol. 2016;1:510-518. doi: 10. 1001/jamacardio. 2016. 1325.